Cardiomyopathy Without Clinically Manifest Skeletal Myopathy in Patients with Variants in Skeletal Myopathy Genes: A Single-Center Cohort Study
Genes · 08.11.2026 · 17 (11) · 1409
DOI: 10.3390/genes17111409 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Genes, online erschienen am 08.11.2026. Verfasst von Miguel López-Tejada und 8 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sociedad Andaluza de Cardiología.
Abstract (Originalsprache)
Background/Objectives: Variants in genes classically associated with skeletal myopathies may be identified in patients with cardiomyopathy without clinically manifest skeletal muscle disease. We aimed to characterize the clinical, imaging, familial, and genetic features of this population.
Methods
We conducted a single-center retrospective study of 33 patients with cardiomyopathy and no clinically manifest skeletal myopathy, comprising 31 laboratory-selected patients and two affected relatives from a previously published ACTA1 family. Clinical, familial, imaging, and genetic data were analyzed, incorporating available disease-specific variant classifications.
Results
Median age at the beginning of cardiac follow-up was 47 years (range 16–77), and 42.4% were male. Dilated cardiomyopathy was the most frequent phenotype (22/33, 66.7%), followed by hypertrophic cardiomyopathy (8/33, 24.2%) and non-dilated left ventricular cardiomyopathy (3/33, 9.1%). ANO5 was the most frequently represented ascertainment gene (12/33, 36.4%). Among patients with complete data, 74.1% had no major conventional cardiovascular risk factors or significant coronary artery disease. Family history of cardiomyopathy was present in 43.8%, and 21 patients had additional genetic findings. Cardiac magnetic resonance was performed in 23 patients; late gadolinium enhancement was present in nine (39.1%), exclusively with non-ischemic patterns.
Conclusions
The cohort describes heterogeneous cardiac presentations in patients carrying variants in skeletal-myopathy-associated genes without clinically manifest skeletal myopathy. These observations support further investigation of potential skeletal–cardiac phenotypic overlap and remain hypothesis-generating without establishing variant-level cardiac causality.
Förderung
- Sociedad Andaluza de Cardiología
Zitieren
APA
López-Tejada, M., Mezcua, A. R., Expósito, A. D., Rubio, C. J., Cabeza, A. P., Camas, P. M., Zamora, H. L., Rodríguez, M. C., & García-Pinilla, J. M. (2026). Cardiomyopathy Without Clinically Manifest Skeletal Myopathy in Patients with Variants in Skeletal Myopathy Genes: A Single-Center Cohort Study. Genes, 17(11), 1409. https://doi.org/10.3390/genes17111409
Vancouver
López-Tejada M, Mezcua AR, Expósito AD, Rubio CJ, Cabeza AP, Camas PM, et al. Cardiomyopathy Without Clinically Manifest Skeletal Myopathy in Patients with Variants in Skeletal Myopathy Genes: A Single-Center Cohort Study. Genes. 2026;17(11):1409. doi:10.3390/genes17111409
BibTeX
@article{LpezTejada2026,
author = {López-Tejada, Miguel and Mezcua, Ainhoa Robles and Expósito, Arancha Díaz and Rubio, Clara Jiménez and Cabeza, Alejandro Pérez and Camas, Paloma Márquez and Zamora, Helena Lemus and Rodríguez, María Campos and García-Pinilla, José Manuel},
title = {Cardiomyopathy Without Clinically Manifest Skeletal Myopathy in Patients with Variants in Skeletal Myopathy Genes: A Single-Center Cohort Study},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1409},
doi = {10.3390/genes17111409}
}
EUVIMED